Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 16051 77 7. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107011354B reveals a high-purity AgNO3/SOCl2 nitration route for 5-ISMN, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel activated carbon purification method reduces energy costs and simplifies scale-up for isosorbide mononitrate manufacturing.
Patent CN110407846A reveals high-purity 5-ISMN synthesis. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN110407846B reveals a novel TMSCl-mediated nitration route for 5-ISMN. Achieve >99% purity and simplified supply chains for cardiovascular intermediates.
Patent CN110407846B introduces a mild, high-selectivity nitration method for 5-ISMN. Discover cost-effective, scalable pharma intermediate manufacturing solutions.
Patent CN104892623B enables high-purity 5-ISMN production. Discover cost reduction in API manufacturing and reliable pharmaceutical intermediates supplier solutions.
Patent CN104892623A reveals high-purity Isosorbide 5-mononitrate synthesis. Enhanced selectivity and cost reduction in pharmaceutical intermediates manufacturing.